Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Khalifa Al Naama"'
Autor:
Hassan Riad, Khaled Mansour, Hussein Al Sada, Khalifa Al Naama, Amal Al Shaigy, Khairunnisa Hussain
Publikováno v:
Case Reports in Dermatology, Vol 5, Iss 3, Pp 272-282 (2013)
A malignant transformation is known to occur in many nevi such as a sebaceous nevus or a basal cell nevus, but a verrucous epidermal nevus has only rarely been associated with neoplastic changes. Keratoacanthoma, multifocal papillary apocrine adenoma
Externí odkaz:
https://doaj.org/article/0c3b552a76a94537bf5320358417ecff
Autor:
Hassan Riad, Samya Abu Shaikha, Hamda Al Ansari, Khalifa Al Naama, Hussein Al Sada, Mariam Al Mansoori
Publikováno v:
Case Reports in Dermatology, Vol 5, Iss 2, Pp 219-224 (2013)
Biologics are very useful medications that changed the lives of many patients in the last decade. However, we still do not know about the long-term side effects of these drugs. Infliximab is an anti-TNF chimeric antibody widely used and approved for
Externí odkaz:
https://doaj.org/article/4b4c8896f6e441519795f88ee55ac8e9
Autor:
Amal Al Shaigy, Khalifa Al Naama, Hassan Riad, Hussein Al Sada, Khaled Mansour, Khairunnisa Hussain
Publikováno v:
Case Reports in Dermatology
Case Reports in Dermatology, Vol 5, Iss 3, Pp 272-282 (2013)
Case Reports in Dermatology, Vol 5, Iss 3, Pp 272-282 (2013)
A malignant transformation is known to occur in many nevi such as a sebaceous nevus or a basal cell nevus, but a verrucous epidermal nevus has only rarely been associated with neoplastic changes. Keratoacanthoma, multifocal papillary apocrine adenoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8464a19570346508938e687352ee318
https://doi.org/10.1159/000355605
https://doi.org/10.1159/000355605
Autor:
Khalifa Al Naama, Hussein Al Sada, Mariam Al Mansoori, Samya Abu Shaikha, Hamda Al Ansari, Hassan Riad
Publikováno v:
Case Reports in Dermatology, Vol 5, Iss 2, Pp 219-224 (2013)
Case Reports in Dermatology
Case Reports in Dermatology
Biologics are very useful medications that changed the lives of many patients in the last decade. However, we still do not know about the long-term side effects of these drugs. Infliximab is an anti-TNF chimeric antibody widely used and approved for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be4295704f7b4db22a9f582faeb74229
http://www.karger.com/Article/FullText/354593
http://www.karger.com/Article/FullText/354593